Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.
Ymmunobio's investors include Innosuisse.
Ymmunobio is headquartered in Basel, Switzerland.
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.
Ymmunobio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ymmunobio — Funding & Investors." VCBacked, November 8, 2024, https://www.vcbacked.co/company/ymmunobio. Accessed August 14, 2026.
VCBacked. (2024). Ymmunobio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ymmunobio
{{cite web |title=Ymmunobio — Funding & Investors |url=https://www.vcbacked.co/company/ymmunobio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated